Shanghai Sureness Biotechnology Co., Ltd. announced that it will receive CNY 199.90 million in a equity round of funding on April 26, 2024. The transaction will include participation from returning investor Shanghai OPM Biosciences Co., Ltd for CNY 199.90 million. This has been approved in the 3rd session of its 2nd directorate and the 2nd session of its 2nd supervisory board of the Shanghai OPM Biosciences Co., Ltd. post-completion of the transaction, registered capital will increase from CNY20 million to CNY200 million.